BIBvsSPYG
ProShares Ultra Nasdaq Biotechnology against SPDR Portfolio S&P 500 Growth ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BIB | SPYG | |
|---|---|---|
| Expense ratio | 0.95% | 0.040% |
| Assets | $93M | $56.6B |
| Net flow, 1 month | −$3M | +$1.1B |
| Net flow, 1 year | −$11M | +$4.8B |
| Return, YTD | +37.6% | +16.8% |
| Return, 1 year | +73.2% | +18.5% |
| Avg daily volume | 8K | 2.1M |
| Holdings | 229 | 228 |
| Listed | Apr 9, 2010 | Sep 25, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS